Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2231096 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL1055187 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL1053266 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL33595 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL9099483 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL9242191 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL1069145 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL3911129 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL749593 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL8416064 | 1.00 | NAAA (0.66) | NAAANPSR1RAD52MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329998-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | CORN PRODUCTS DEVELOPMENT, INC. (INCORPORATED IN DE) | 2023-10-19 | — | — | US | disclosed |
| CN-107312102-B | Modified polysaccharides | 玉米产品开发公司 | 2021-11-23 | — | — | CN | disclosed |
| CN-107087396-B | Personal care products comprising highly cationically substituted starch | 玉米产品开发公司 | 2021-11-02 | — | — | CN | disclosed |
| EP-3180089-B1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | CORN PRODUCTS DEV INC (BR) | 2020-07-08 | — | — | EP | disclosed |
| US-10143643-B2 | Modified polysaccharides | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2018-12-04 | — | — | US | disclosed |
| EP-3239180-B1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEV INC (BR) | 2018-11-28 | — | — | EP | disclosed |
| US-20180263886-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | CORN PRODUCTS DEV INC (US) | 2018-09-20 | — | — | US | disclosed |
| US-20180071195-A1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2018-03-15 | — | — | US | disclosed |
| US-20180071196-A1 | COMPOSITIONS COMPRISING MODIFIED POLYSACCHARIDES AND USES THEREOF | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2018-03-15 | — | — | US | disclosed |
| US-9820928-B1 | Modified polysaccharides | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2017-11-21 | — | — | US | disclosed |
| US-20170312213-A1 | MODIFIED POLYSACCHARIDES | CORN PRODUCTS DEVELOPMENT, INC. (BR) | 2017-11-02 | — | — | US | disclosed |
| EP-3239180-A1 | MODIFIED POLYSACCHARIDES | Corn Products Development, Inc. (BR) | 2017-11-01 | — | — | EP | disclosed |
| EP-3180089-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | Corn Products Development, Inc (BR) | 2017-06-21 | — | — | EP | disclosed |
| WO-2016025240-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | PENFORD PRODUCTS CO. (US) | 2016-02-18 | — | — | WO | disclosed |
| US-20160038397-A1 | Personal Care Products Comprising Highly Cationic Substituted Starches | CORN PRODUCTS DEVELOPMENT, INC. (INCORPORATED IN DE) (BR) | 2016-02-11 | — | — | US | disclosed |
| US-5547500-A | CONTAINING A LEUCO COMPOUND | RICOH COMPANY, LTD. (JP) | 1996-08-20 | — | — | US | disclosed |
| US-5379058-A | Recording apparatus using a thermosensitive recording medium | RICOH COMPANY, LTD. (JP) | 1995-01-03 | — | — | US | disclosed |
| EP-0432594-A2 | Acyl malate diesters | HAARMANN & REIMER CORP. (US) | 1991-06-19 | — | — | EP | disclosed |
| US-5015418-A | Substitute fats for foods | HAARMANN & REIMER CORP. (US) | 1991-05-14 | — | — | US | disclosed |
| US-4078147-A | COSMETICS, EMULSIONS, SOAPS, RINSES | THE NISSHIN OIL MILLS, LTD. (JA) | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180071195-A1 | MODIFIED POLYSACCHARIDES | ALG1, HDAC1, CSGALNACT1 | NAAA 3490/4885NPSR1 1687/4885RAD52 3878/4885 |
| US-20160038397-A1 | Personal Care Products Comprising Highly Cationic Substituted Starches | DSG1, CUTA, AMY1A | NAAA 1473/4885NPSR1 4479/4885RAD52 607/4885 |
| US-20230329998-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | DSG1, CUTA, AMY1A | NAAA 1473/4885NPSR1 4479/4885RAD52 607/4885 |
| US-20170312213-A1 | MODIFIED POLYSACCHARIDES | ALG1, HDAC1, CSGALNACT1 | NAAA 3490/4885NPSR1 1687/4885RAD52 3878/4885 |
| US-20180071196-A1 | COMPOSITIONS COMPRISING MODIFIED POLYSACCHARIDES AND USES THEREOF | ALG1, CD44, CSGALNACT1 | NAAA 3891/4885NPSR1 2005/4885RAD52 4174/4885 |
| US-20180263886-A1 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | DSG1, CUTA, AMY1A | NAAA 1473/4885NPSR1 4479/4885RAD52 607/4885 |
| US-10143643-B2 | Modified polysaccharides | ALG1, HDAC1, CSGALNACT1 | NAAA 3490/4885NPSR1 1687/4885RAD52 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.